Longitudinal Neuroimaging Analysis in Mild-Moderate Alzheimer's Disease Patients Treated with Plasma Exchange with 5% Human Albumin.
Cuberas-Borrós G, Roca I, Boada M, Tárraga L, Hernandez I, Buendia M, Rubio L, Torres G, Bittini Á, Guzmán-de-Villoria JA, et al.
